Sinonasal adenoid cystic carcinoma: a population-based analysis of 694 cases

Aykut A Unsal, Sei Y. Chung, Albert H. Zhou, Soly Baredes, Jean Anderson Eloy

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Currently, limited literature exists about sinonasal adenoid cystic carcinoma (SNACC). In this study, we analyze the demographics, survival, and treatment efficacy of this rare entity. Methods: Our study was a retrospective population-based analysis of SNACC in the Surveillance, Epidemiology, and End Results (SEER) database assessing the 40-year time-frame of 1973 to 2013. Results: Six hundred ninety-four SNACC patients were identified; 53.2% were female and 46.8% were male. Caucasians were most commonly affected (77.1%). SNACC most often arose from the maxillary sinuses, followed by the nasal cavity. The majority of SNACC cases presented as stage IV disease. Nodal and distant metastases were present in 3.6% and 7.1% of all cases, respectively. Overall 5-, 10-, and 20-year disease-specific survival (DSS) rates were 66.5%, 41.1%, and 17.6%, respectively. The presence of distant metastasis dropped the 5-year DSS rate from 64.5% to 20.0%. Cases treated with combined surgery and adjuvant radiotherapy had a slightly improved 5-year DSS rate compared with surgery alone (73.5% vs 72.5%). Surgery alone resulted in higher 10- and 20-year DSS rates (54.2% and 36.8%, respectively) when compared with combined therapy (44.2% and 15.5%), radiotherapy alone (10.8% and 0%), and no surgery or radiotherapy (9.3% and 0%). Conclusion: This study represents the largest cohort of SNACC patients to date. Factors that confer a survival benefit in SNACC include M0 disease, and presentation primarily in the nasal cavity. Overall low rates of nodal metastasis may not warrant the use of elective neck dissections, unless there is clinical suspicion. Modalities of therapy that include surgery greatly improve survival. Adjuvant radiotherapy appears to slightly improve 5-year disease-free survival but does not impact long-term survival.

Original languageEnglish (US)
Pages (from-to)312-320
Number of pages9
JournalInternational Forum of Allergy and Rhinology
Volume7
Issue number3
DOIs
StatePublished - Mar 1 2017
Externally publishedYes

Fingerprint

Adenoid Cystic Carcinoma
Population
Survival Rate
Adjuvant Radiotherapy
Nasal Cavity
Neoplasm Metastasis
Survival
Radiotherapy
Neck Dissection
Maxillary Sinus
Survival Analysis
Disease-Free Survival
Epidemiology
Demography
Databases
Therapeutics

Keywords

  • SEER
  • Surveillance Epidemiology and End Results
  • adenoid cystic carcinoma
  • disease-specific survival
  • incidence
  • population-based
  • sinonasal adenoid cystic carcinoma
  • sinonasal cancer
  • sinonasal cancer
  • survival

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Sinonasal adenoid cystic carcinoma : a population-based analysis of 694 cases. / Unsal, Aykut A; Chung, Sei Y.; Zhou, Albert H.; Baredes, Soly; Eloy, Jean Anderson.

In: International Forum of Allergy and Rhinology, Vol. 7, No. 3, 01.03.2017, p. 312-320.

Research output: Contribution to journalArticle

Unsal, Aykut A ; Chung, Sei Y. ; Zhou, Albert H. ; Baredes, Soly ; Eloy, Jean Anderson. / Sinonasal adenoid cystic carcinoma : a population-based analysis of 694 cases. In: International Forum of Allergy and Rhinology. 2017 ; Vol. 7, No. 3. pp. 312-320.
@article{86a447247dcd4be0a53bc7978c26e05e,
title = "Sinonasal adenoid cystic carcinoma: a population-based analysis of 694 cases",
abstract = "Background: Currently, limited literature exists about sinonasal adenoid cystic carcinoma (SNACC). In this study, we analyze the demographics, survival, and treatment efficacy of this rare entity. Methods: Our study was a retrospective population-based analysis of SNACC in the Surveillance, Epidemiology, and End Results (SEER) database assessing the 40-year time-frame of 1973 to 2013. Results: Six hundred ninety-four SNACC patients were identified; 53.2{\%} were female and 46.8{\%} were male. Caucasians were most commonly affected (77.1{\%}). SNACC most often arose from the maxillary sinuses, followed by the nasal cavity. The majority of SNACC cases presented as stage IV disease. Nodal and distant metastases were present in 3.6{\%} and 7.1{\%} of all cases, respectively. Overall 5-, 10-, and 20-year disease-specific survival (DSS) rates were 66.5{\%}, 41.1{\%}, and 17.6{\%}, respectively. The presence of distant metastasis dropped the 5-year DSS rate from 64.5{\%} to 20.0{\%}. Cases treated with combined surgery and adjuvant radiotherapy had a slightly improved 5-year DSS rate compared with surgery alone (73.5{\%} vs 72.5{\%}). Surgery alone resulted in higher 10- and 20-year DSS rates (54.2{\%} and 36.8{\%}, respectively) when compared with combined therapy (44.2{\%} and 15.5{\%}), radiotherapy alone (10.8{\%} and 0{\%}), and no surgery or radiotherapy (9.3{\%} and 0{\%}). Conclusion: This study represents the largest cohort of SNACC patients to date. Factors that confer a survival benefit in SNACC include M0 disease, and presentation primarily in the nasal cavity. Overall low rates of nodal metastasis may not warrant the use of elective neck dissections, unless there is clinical suspicion. Modalities of therapy that include surgery greatly improve survival. Adjuvant radiotherapy appears to slightly improve 5-year disease-free survival but does not impact long-term survival.",
keywords = "SEER, Surveillance Epidemiology and End Results, adenoid cystic carcinoma, disease-specific survival, incidence, population-based, sinonasal adenoid cystic carcinoma, sinonasal cancer, sinonasal cancer, survival",
author = "Unsal, {Aykut A} and Chung, {Sei Y.} and Zhou, {Albert H.} and Soly Baredes and Eloy, {Jean Anderson}",
year = "2017",
month = "3",
day = "1",
doi = "10.1002/alr.21875",
language = "English (US)",
volume = "7",
pages = "312--320",
journal = "International Forum of Allergy and Rhinology",
issn = "2042-6976",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Sinonasal adenoid cystic carcinoma

T2 - a population-based analysis of 694 cases

AU - Unsal, Aykut A

AU - Chung, Sei Y.

AU - Zhou, Albert H.

AU - Baredes, Soly

AU - Eloy, Jean Anderson

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Currently, limited literature exists about sinonasal adenoid cystic carcinoma (SNACC). In this study, we analyze the demographics, survival, and treatment efficacy of this rare entity. Methods: Our study was a retrospective population-based analysis of SNACC in the Surveillance, Epidemiology, and End Results (SEER) database assessing the 40-year time-frame of 1973 to 2013. Results: Six hundred ninety-four SNACC patients were identified; 53.2% were female and 46.8% were male. Caucasians were most commonly affected (77.1%). SNACC most often arose from the maxillary sinuses, followed by the nasal cavity. The majority of SNACC cases presented as stage IV disease. Nodal and distant metastases were present in 3.6% and 7.1% of all cases, respectively. Overall 5-, 10-, and 20-year disease-specific survival (DSS) rates were 66.5%, 41.1%, and 17.6%, respectively. The presence of distant metastasis dropped the 5-year DSS rate from 64.5% to 20.0%. Cases treated with combined surgery and adjuvant radiotherapy had a slightly improved 5-year DSS rate compared with surgery alone (73.5% vs 72.5%). Surgery alone resulted in higher 10- and 20-year DSS rates (54.2% and 36.8%, respectively) when compared with combined therapy (44.2% and 15.5%), radiotherapy alone (10.8% and 0%), and no surgery or radiotherapy (9.3% and 0%). Conclusion: This study represents the largest cohort of SNACC patients to date. Factors that confer a survival benefit in SNACC include M0 disease, and presentation primarily in the nasal cavity. Overall low rates of nodal metastasis may not warrant the use of elective neck dissections, unless there is clinical suspicion. Modalities of therapy that include surgery greatly improve survival. Adjuvant radiotherapy appears to slightly improve 5-year disease-free survival but does not impact long-term survival.

AB - Background: Currently, limited literature exists about sinonasal adenoid cystic carcinoma (SNACC). In this study, we analyze the demographics, survival, and treatment efficacy of this rare entity. Methods: Our study was a retrospective population-based analysis of SNACC in the Surveillance, Epidemiology, and End Results (SEER) database assessing the 40-year time-frame of 1973 to 2013. Results: Six hundred ninety-four SNACC patients were identified; 53.2% were female and 46.8% were male. Caucasians were most commonly affected (77.1%). SNACC most often arose from the maxillary sinuses, followed by the nasal cavity. The majority of SNACC cases presented as stage IV disease. Nodal and distant metastases were present in 3.6% and 7.1% of all cases, respectively. Overall 5-, 10-, and 20-year disease-specific survival (DSS) rates were 66.5%, 41.1%, and 17.6%, respectively. The presence of distant metastasis dropped the 5-year DSS rate from 64.5% to 20.0%. Cases treated with combined surgery and adjuvant radiotherapy had a slightly improved 5-year DSS rate compared with surgery alone (73.5% vs 72.5%). Surgery alone resulted in higher 10- and 20-year DSS rates (54.2% and 36.8%, respectively) when compared with combined therapy (44.2% and 15.5%), radiotherapy alone (10.8% and 0%), and no surgery or radiotherapy (9.3% and 0%). Conclusion: This study represents the largest cohort of SNACC patients to date. Factors that confer a survival benefit in SNACC include M0 disease, and presentation primarily in the nasal cavity. Overall low rates of nodal metastasis may not warrant the use of elective neck dissections, unless there is clinical suspicion. Modalities of therapy that include surgery greatly improve survival. Adjuvant radiotherapy appears to slightly improve 5-year disease-free survival but does not impact long-term survival.

KW - SEER

KW - Surveillance Epidemiology and End Results

KW - adenoid cystic carcinoma

KW - disease-specific survival

KW - incidence

KW - population-based

KW - sinonasal adenoid cystic carcinoma

KW - sinonasal cancer

KW - sinonasal cancer

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=84997108060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997108060&partnerID=8YFLogxK

U2 - 10.1002/alr.21875

DO - 10.1002/alr.21875

M3 - Article

C2 - 27863150

AN - SCOPUS:84997108060

VL - 7

SP - 312

EP - 320

JO - International Forum of Allergy and Rhinology

JF - International Forum of Allergy and Rhinology

SN - 2042-6976

IS - 3

ER -